Cancer calculators

Here, an overview is provided with a list of calculators that is incomplete and based on limited searches (but excluding calculators such as for treatment choices, doses, organ function). There is no endorsement attached to inclusing or non-inclusion in the list. Visitors are invited to make suggestions in the comment boxes below.

To this post and every entry in the list applies this: it does not provide medical advice and should not be seen as providing any medical advice. The list is exclusively for information purposes about the existance of such calculators. Always seek advice of a physician or qualified health care provider. The provider of paediatricdata.eu is not affiliated with any provider of the listed calculators.

The calculators are typically based on one or more clinical studies and scientific publications, and they serve various purposes (column "Type"), such as

  • estimating the future risk for developing a cancer or for a cancer to occur
  • estimating the prognosis based on patient and cancer characteristics, before treatment
  • estimating a treatment effect (of specific interventions) on an outcome
  • estimating treatment-related mortality
  • estimating a residual cancer burden
  • estimating the risk for recurrence of a cancer
  • estimating outcomes such as overall or disease-free survival

Cancer risks, prognosis and outcomes calculaters

The table is populated with references to various websites that offer tools into which individual patient information can be entered in order to calculate the patient's risks and outcomes. Some calculators provide nomograms, others specific estimates. Keywords and other information was added to enhance the overview but without any claim this is correct; visitors are invited to comment below. Links open in a new window or tab of the browser.
#CancerTypeUpdatedProviderFundingLink
1Breast, OvarianRisk2024-04-05University of Cambridge (UK)Cancer Research UK; Horizon 2020; Genome Canada; Wellcome Trusthttps://www.canrisk.org/
2BreastTreatment effect2024University of Cambridge (UK)Cedars Sinaihttps://breast.v3.predict.cam/
3ProstateRiskStichting Wetenschappelijk Onderzoek Prostaatkanker (NL)Including European Randomized Study of Screening for Prostate Cancer (ERSPC)https://www.prostatecancer-riskcalculator.com/seven-prostate-cancer-risk-calculators
4ProstateTreatment effect2019University of Cambridge (UK)Public Health Englandhttps://prostate.predict.nhs.uk/
5MedulloblastomaOutcome2023Kuo C et al.Publicationhttps://thejns.org/pediatrics/view/journals/j-neurosurg-pediatr/33/1/article-p85.xml
6Kidney; Prostate; Bladder; Testis; Penile; Adrenal; UrothelialPrognosis; Recurrence; OutcomeVariousTemple University Health System, Inc. (US)For profit; donationshttps://cancernomograms.com/nomograms/
7Breast; Colorectal; Oesophagus; PancreaticPrognosis; Treatment effect; OutcomeVariousMD Anderson Center (US)https://www.mdanderson.org/for-physicians/clinical-tools-resources/clinical-calculators.html
8MelanomaRisk; Prognosis; Treatment effect; OutcomeVariousMelanoma Institute AustraliaNot-for-profit, donationshttps://www.melanomarisk.org.au/
9KidneyTreatment effect; Outcome2021Fred Hutch Cancer Center (US)Not-for-profithttps://small-renal-mass-risk-calculator.fredhutch.org/
10OesophagusRisk2019Fred Hutch Cancer Center (US)Not-for-profithttps://ic-risc.fredhutch.org/
11Acute myeloid leukaemiaPrognosis2017Fred Hutch Cancer Center (US)Not-for-profithttps://www.fredhutch.org/en/research/divisions/clinical-research-division/research/aml-treatment-tools/physician.html
12VariousPrognosis; Recurrence; OutcomeVariousMDCalc Ltd. Inc.For profithttps://www.mdcalc.com/#Specialty
13ProstateRisk2018UT Health San Antonio (US)https://riskcalc.org/PCPTRC/
14KidneyTreatment effect2022Msaouel P et al.Publicationhttps://www.mdpi.com/2072-6694/14/16/3923#app1-cancers-14-03923
15Acute myeloid leukaemiaTreatment-related mortality2011Fred Hutch Cancer Center (US)Not-for-profithttps://trmcalculator.fredhutch.org/


Leave a Reply

Your email address will not be published. Required fields are marked *